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Abstract 
Bacterial persister cells present a growing concern as they inherit the ability to 
tolerate high concentrations of antibiotics and repopulate after an antibiotic 
treatment leading to chronic diseases.  Pseudomonas aeruginosa causes many 
human infections including skin infections and those associated with burn 
injuries, and implanted medical devices, and are associated with Cystic Fibrosis.  
Recently, the Ren Lab developed a novel approach to eliminate persister cells of 
P. aeruginosa, including those in biofilms, using low level electric currents.  To 
evaluate the safety of this method and to better understand how the underlying 
elements, this study focused on the cytotoxicity of treatments with low level DCs 
to different human cell lines, effects on P. aeruginosa in co-culture with human 
cells, and protein expression of P. aeruginosa in response to DC treatments.  Four 
human cell lines, Lung Cancer 5803, Lung Cancer 5908, Breast Cancer 231, and 
Fibroblast cells, were tested for cytotoxicity during DC treatment.  Treatment 
with 70 μA/cm2 DC with 4.0 μg/mL tobramycin led to a two-log killing of P. 
aeruginosa and 90%+ survival of mammalian cells.  Consistently, the proteomic 
revealed the stress response in P. aerigunosa was induced by DC treatment.  
These findings provide new in insight in bacterial control with DCs which will 
help further development of this technology. 
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1. Introduction 
There is an ever increasing concern over the rapid development and spread of 
bacteria that are resistant to multiple antibiotics.  Such bacteria present a major 
threat to of public health and economy.  Bacteria can grow both as individual cells 
(planktonic) and in multi-cellular communities attached to surfaces, known as 
biofilms.  The formation of 
biofilms provides an ideal 
condition for the development 
of multi-antibiotic resistant 
strains of bacteria.  Biofilms 
are commonly found on 
infected tissues and implanted 
medical devices causing 
chronic infections in human 
bodies with high mortality and morbidity.  For some bacterial species, biofilm 
formation is critical for survival in hostile environments because the cells benefit 
from the protection of a hydrated matrix of protein and polysaccharide.  As 
exemplified in Figure 1, biofilm formation starts with individual cells irreversibly 
attached to a surface followed by microcololony formation, maturation, and 
dispersion.  These microcolonies are organized with functional heterogeneity to 
allow the transfer of nutrients and metabolic wastes[8]. 
Most antibiotics are unable to penetrate the exopolysaccharide  (EPS) matrix to 
reach individual cells because the polymeric substances that construct the biofilm 
Figure 1: The Five Stages of Pseudomonas 
aeruginosa growth on biofilms:  
Stage 1, early attachment; Stage 2, irreversible 
attachment; Stage 3, primary maturation; Stage 4, 
secondary maturation; Stage 5, dispersion [3] 
  
 
 
matrix slowing down diffusion.  Further evidence points out that the cells in the 
inner layers of bofiloms receive less nutrients and are not susceptible to 
antibiotics in their nutrient deficient starving state [1,2,5]. 
Another mechanism of antibiotic tolerance is persister formation.  Persister cells 
do not die when antibiotics are administered allowing them to remain in the body 
until an antibiotic regime has concluded.  At this point, persister cells are able to 
return to normal cells and grow rapidly causing chronic infections that can lead to 
extended hospital stays and potentially death depending on the physical condition 
and immunity of the patient [9]. 
The Gram-negative bacterium, Pseudomonas aeruginosa, can be found in both 
natural environments and disease conditions.  It is highly versatile because of its 
ability to grow under many different conditions and to elevate a variety of stress 
responses.  Because it is a Gram-negative bacterium, P. aeruginosa has the 
presence of an outer membrane made up of some lipopolysaccharides and 
proteins that is not present in Gram-positive bacteria.  This outer membrane is 
important for the study of this bacterium as it helps with the resistance to 
antibiotics by halting the diffusion of antibiotic into the cell.  P. aeruginosa is an 
opportunistic pathogen that infects patients with cystic fibrosis and in persons 
with compromised immune systems (i.e. HIV/AIDS).  For patients with cystic 
fibrosis, P. aeruginosa presents a serious problem because 80% of the population 
gets infected by this bacterium [4].  As discussed by Davies JC, P. aeruginosa is 
the main pathogen found in lungs of cystic fibrosis patients.  It is thought that the 
accumulation of mucus in the airways leads to the breakdown of antibacterial 
  
 
 
peptides as well as increased bacterial receptors on the membranes of eukaryotic 
cells, and a decreased ability to fight against infection due to the lack in essential 
molecules such as nitric oxide and glutathione [15]. 
 Like many other pathogenic bacteria, P. aeruginosa can form biofilms and 
persister cells, which are tolerant to most, if not all, antibiotics.  Recently, the Ren 
Lab developed a novel approach to eliminate persister cells of P. aeruginosa, 
including those in biofilms, using low level electric currents.  Research using the 
bioelectric effect originated in the 1950s and has continuously progressed to 
include a multitude of areas of research, but research with its advantages when 
used against biofilm formation started only in the 1990s. 
A phenomenon named, bioelectric effect, was reported by Costerton and co-
workers that low level electric fields produced by electric currents can enhance 
the efficacy of the antibiotics against bacterial biofilms.  Research has shown the 
amount of antibiotic required to control biofilm cells decreases in the presence of 
electric current.  Alternating current (AC) and direct current (DC) have shown to 
be effective.  This is especially important to fight biofilm infections because it 
allows the doses of antibiotics to be reduced to clinically and physiologically 
acceptable values.  Normally, antibiotics alone are not effective against biofilms 
due to their high tolerance, up to 1000 times higher than planktonic cells. 
The use of the bioelectric effect has proven to be promising thus far.  The use of 
DC current alone has shown to 1 log reduction in CFU/mL.  This phenomenom 
has been tested and proven for P. aeruginosa, Staphylococcus epidermis, 
Staphylococcus gordonii, Candida albicans, and Klebsiella pneumonia with 
  
 
 
tobramycin, gentamicin, and cycloheximide [6, 7, 14].  The exact mechanism by 
which the bioelectric effect enables for a large increase in bacterial killing, 
however, is not well understood. 
Recently, the Ren Lab reported that low level DCs can also sensitize persister 
cells to antibiotics.  This study focuses on the killing of planktonic bacteria cells 
(PAO1) by the efficacy of combining low level electrical currents with the 
antibiotic tobramycin.  Further, the study examines the potential cytotoxic effects 
of low level electrical currents on representative mammalian cells to determine if 
this method can be safely integrated into medical applications.  Finally, the last 
part of the study aims to gain a better understanding of how extracellular protein 
expression changes during electrical treatment of PAO1.  By separating cellular 
proteins and comparing the protein expression profiles of the control and treated 
samples, we expect to obtain new insight into persister control by low-level DCs.  
Proteomics allows quantitative comparison of proteins expression under different 
conditions.  It was hypothesized that EC treatment can induce and repressed 
different sets of proteins in P. aeruginosa cells. Thus, by comparing a control 
sample (no EC treatment) with an experimental sample (EC treatment), the 
physiological changes in cells can be investigated at the protein level. 
Great importance is also put on the need to study the cytotoxicity of the EC 
treatment on human cells.  Although the EC treatment proves to be effective in 
the killing of persister cells, it is necessary to prove that there are no significant 
effects of EC treatment on human cells.  In this study, we characterized the 
viability of LC 5908, LC 5803, and BC 231 with treatment of 70 μA/cm2 and 84 
  
 
 
μA/cm2.  We further tested the killing of P. aeruginosa PAO1 in co-cultures with 
tobramycin and 500 μA DC.  To my best knowledge, this is the first study to 
investigate the cytotoxicity of low level DCs on LC 5908 and LC 5803 cells, to 
test the effects of DCs on P. aeruginosa  in co-culture with and to compare 
protein expression profiles of P. aeruginosa in response to DCs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
2. Materials and Methods 
2. 1 DC treatment of human cells in a planktonic suspension 
Two experimental groups were studied to determine the effects of an applied 
electrical field on varying cultures of mammalian cells.  An electrochemical cell 
(Figure 3)  was created by putting two stainless steel 304 (SS 304) electrodes 
inside a cuvette.  An Ag/AgCl reference electrode was used to maintain a steady 
current load.  Two current densities were used to test the effects of DC on cell 
viability, 70 µA/cm2 (500µA) and 84 
µA/cm2 (600µA).  The cell lines tested 
were Lung Cancer 5908, Lung Cancer 
5803, and Breast Cancer 231 (obtained 
from Dr. Jing An at SUNY Upstate 
Medical University).  Initially fiber blast 
cells were also included in the cells, but 
issues with cell proliferation led to their 
exclusion from the study.  All cell lines 
were grown in T-flasks, each containing 
25mL the phosphate dense Roswell Park 
Memorial Institute medium supplemented 
with 10% Fetal Bovine Serum (FBS) and 
1% Glutamine-Penicillin-Streptomycin (GPS) for 7-8 days.  The cells are cultured 
with 5% CO2 at 37°C and the medium was replenished every 4 days.  To harvest 
cells, the medium was removed using a pipet and TE buffer containing 0.25% 
Image 2: Display of how the 
bioelectric effect is set up.  Cells 
are suspended in the cuvette 
shown here 
  
 
 
Trypsin and 0.53mM EDTA added and let sit for 15 minutes to break apart 
proteins in the extracellular matrix.  The cells were re-suspended in 10mL RPMI 
were transferred to a conical tube and centrifuged at 1000 rpm for three minutes.  
The suspension was discarded and 0.85% NaCl solution was added to the solution 
to re-suspend the cells for testing.  For each test, 3 mL of the mixture was put into 
a sterile cuvette and the electrochemical cell was assembled using the two SS 304 
coupons and an Ag/AgCl reference electrode.  The flow of electricity was set and 
monitored by the AfterMath Scientific Data Organizer Software (Pine Research 
Instrumentation).  The program was set to run at the desired current for sixty 
minutes.  At time zero, twenty minutes, forty minutes, and sixty minutes, 40 µL of 
sample was extracted and dyed with 10 µL of Trypan blue.  Ten µL of the mixture 
was put onto a hemocytometer.  A hemocytometer is a special slide used to count 
cells in four different grid quadrants.  The cell membrane color number and color 
were recorded to determine the viability at 20 minute intervals during the one-
hour treatment. 
2.2 Effect of DC on the viability of human cells infected with PA01 
Mammalian cells were collected after incubation for 7-8 days and collected with 
TE buffer and centrifuged at 1000 rpm for 3 minutes as described above.  Cells 
were then re-suspended in 0.85% NaCl.  Concurrently, P. aeruginosa PA01 cells 
were collected from a 25 mL overnight culture by taking 10mL of the culture and 
adding it to a 25 mL conical tube.  The PA01 were prepared from a 25mL 
overnight culture in Luria-Bertani (LB) medium containing 10 g/L yeast extract, 
and 10 g/l NaCl [16].  The tube was centrifuged for 10 minutes at 1000rpm.  The 
  
 
 
supernatant was discarded and the cells were re-suspended in equal amounts of 
0.85% NaCl, mixed using a vortex, then centrifuged for 10 minutes at 1000 rpm.  
This step was then repeated one more time.  Using a cuvette with 3 mL 0.85% 
NaCl buffer as a reference, the OD600 of the 3mL of the PA01 suspension was 
adjusted to reach OD600=0.6 for co-culture experiment.  OD or optical density is a 
measure of the amount of light absorbed by a suspension.  In this case the 
suspension contains PA01 and 0.85% NaCl was used as a baseline such that 
measuring the OD600 of PA01 does not take into the account the presence of the 
buffer.  Once the OD600 was measured, the sample was diluted such that an 
OD600=0.6 was added to the human cells.  Upon infection, a current density of 
70µA/cm2 was applied for 1 hour using SS 304 electrodes and an Ag/AgCl 
reference electrode to create an electrochemical cell (Figure 3).  The Trypan Blue 
excision method was used to determine the cell viability of human cells during the 
one-hour treatment.  Also at twenty minute intervals the number of viable PA01 
cells was quantified by counting colony forming unit (CFU).  CFU is a technique 
to approximate the number of bacterial cells in a sample by diluting and ploting 
bacterial cells on agar plates (1.5% agar).  The process uses 96 well plates with 
the addition of 180µL of 0.85% NaCl into an area of 5x7 wells for each sample.  
During testing, 20µL of the solution was put into the 5 wells in the first row.  By 
pipetting 20µL of this mixture, after mixing, to the second row, the concentration 
of bacteria is effectively diluted by a factor of ten.  Continual dilutions allow 
accurate count of bacterial cells. 
 
  
 
 
 2.3 Proteomics 
Step 1: Protein sample preparation 
To obtain quality 2DE images it is important to know the optimal level of 
sonication to break the cells.  To do this, P. aeruginosa samples were extracted 
and sonicated at the following settings of power and time: 50% 1:30 min, 50% 
2:00 min, 50% 3:00 min, 75% 1:30 min, 75% 2:00 min, 75% 3:00 min, 100% 
1:30 min, 100% 2:00 min, and 100% 3:00 min.  For this test, protein samples 
were extracted from the pellet and supernatant to better understand how the 
amount of proteins varied with increased sonication.  A following test was 
conducted with 100% sonication at intervals of 1:00 min, 2:00 min, 3:00 min, 
4:00 min, and 5:00 min with the addition of 200 µL of lysis buffer.  For 
information for extraction techniques refer to Step 1 in part 2.4.  Note: for the first 
test no lysis buffer was used and the sonication information was not available at 
the time of this experiment. 
Step 2: 1D gel preparation and running 
To make 1D gels, the following recipe is used to make two gels (12% 
acrylamide): 
Distilled water   5.1 mL 
 0.5M Tris-HCl, pH 6.8  2.5 mL 
 10% (w/v) SDS stock   100 µL 
 Acrylamide/ Bis (40% stock)  975 µL 
 10% ammonium persulfate  50 µL 
 Temed     10 µL 
  
 
 
Once the gel solution is made it is poured into a cassette then a comb is placed on 
top to make the wells for running the proteins.  To run the mixture a running 
buffer is used.  Running buffer is made with glycine (115.2g), Tris (24g), SDS 
(4g), and dH2O (qs to 4L).  The cassettes run until the bands reach the bottom of 
the gels 
When loading the individual wells with proteins, each sample is died with 
bromophenol blue before addition. 
Step 3:1D gel imaging 
Gels are imaged on the Molecular Imager Gel Doc XR+ System with Image Lab 
Software using a 1D gel imaging protocol. 
2.4 Variable protein expression mapping due to electrochemical treatment 
Step 1: Protein sample preparation 
A control and experimental sample of PA01 were prepared from a 25mL 
overnight culture in Luria-Bertani (LB) medium containing 10 g/L tryptone, 5 g/L 
yeast extract, and 10 g/l NaCl. Overnight cultures were shaken at 200 rpm and 
incubated at 37 °C.  Samples were prepared by centrifuging samples at 8,000 rpm 
at 4°C, 10 min, and washed with Solution W (KCl [3mM] 22.5mg, KH2PO4 
1.5mM] 20.5mg, NaCl [68mM] 400mg, Na H2PO4 [9mM] 108mg, and dH2O 
100mL).  The process was repeated three times.  Samples are mixed by pipetting 
(avoid vortexing). The amount of lysis buffer needed is calculated such that the 
final protein concentration is between 5-7 mg/mL by the following:  
1 OD = 1mg/mL of cell mass 
Protein = 55% of cell mass 
  
 
 
 Ex: 5mL culture with OD=0.6 will have   
  5mL x 0.6 x 1mg/mL x 55% = 1.65mg protein  
The samples are then frozen over dry ice then thawed with running tap water and 
a vortex is used to mix for ten seconds.   The sonicator is used on the 100% pulse 
setting (10 seconds on, 10 seconds off) for two, two and a half minute intervals 
with the tubes suspended in ice cold water.  Samples are then centrifuged at 13.2k 
rpm and 4°C for a minimum of 45 minutes, but preferentially 60+ minutes.  The 
supernatant is then transferred to a new microcentrifuge tube. 
Step 2: Rehyrdation 
The rehydration mixture follows for each sample: 
Protein sample             42 µL 
 Soln A                          60 µL 
 Rehydration buffer       298 µL             
The mixture is then pipetted into a channel of an Immobile Strip Tray plate.  After 
an Immobile DryStrip is placed gel side down, the protective peel is taken off and 
it is cut to fit the tray.  Ensure optimal absorption of protein by pushing out any 
air bubbles under the strip.  The addition of ~1.5mL of mineral oil on top of the 
strip prevents the strip from drying.  The strips must remain overnight to incubate. 
Step 3: 1-D: IsoElectric Focusing (IEF) 
First electrode wicks are placed on top of the wires of the acidic and basic ends of 
the Multiphor plate to enable the transfer of electricity from the salts to the gel 
strip without direct contact.  Immobile DryStrips (Bio-Rad) are then transferred 
after letting excess mineral oil drip off and placed gel side up.  Addition of ~2mL 
  
 
 
is used to cover the strips.  Check that the tray is in proper orientation before 
running the program on the IEF machine.  The program should be set as: 
 500V, 2 min, rapid 
3500V, 24 hr, rapid 
50µA/gel 
Note: ensure to put into the IEF machine program the number of gels so it reaches 
set voltages. 
Step 4: Gel Preperation 
A large Büchner flask or sidearm flask is used to mix: 
 Tris dH2O PDA 40% acrylamide soln 0% APS       TEMED 
1 gel: 22mL 35.82mL  0.2645g  24.78mL  100µL  45µL 
2 gels: 44mL 71.64mL 0.528g  49.56mL  165µL  75µL 
APS solution is made by diluting 0.05g in 500µL dH2O (for two samples, save the 
extra 150uL for each sample for later). 
The contents must be added from left to right.  Before the addition of 40% 
acrylamide solution, the mixture is mixed well.  Once the 40% acrylamide 
solution is added, the solution is de-gased for 10 minutes under a hood with a 
vacuum and a rubber stopper to reduce the presence of volatile acrylamide 
monomers.  The addition of 10% APS and TEMED are added in a circular 
mixture with gentle swirling to initiate polymerization.  The solution is poured 
into the top of the gel cassettes leaving about 2cm of space from the top.  One to 
two mL of saturated sec-Butanol is added to top of the gel to create an even gel 
matrix.  The gel should sit for at least 2 hours to polymerize.  Excess APS and 
some TEMED are used to polymerize excess solution. 
  
 
 
Step 5: 2-D Polyacrylamide Gel Electrophoresis (PAGE) 
Upon the completion of 1-D IEF, the machine is unplugged and the tray is drained 
of the mineral oil.  The gel strips are then transferred onto the Immobile Tray gel 
side up adding ~3mL of E1 onto each strip and placing it onto a rocker for fifteen 
minutes.  After draining E1 from the tray, the strips are washed off with dI H2O, 
then ~3mL of E2 is added to each strip and it is put on the rocker for five minutes.  
E2 is then drained from the tray.  E1 and E2 are made from the same base 
solution, Solution C, which follows this recipe: 
Urea [6M]  9g 
Glycerol  6mL 
 SDS [2%]  0.5g 
0.05M Tris pH6.8 11.75mL 
To make E1, 0.12 g DTT [2%] is added to 3 mL of solution C.  To make E2, 
0.15g of Iodoacetamide [2.5%] and a few grains of bromophenol blue are added 
to 3mL of solution C. 
Before putting the strips into the glass cassettes, dI H2O is added to the top of the 
gel.  Strips have to be trimmed in order to properly fit into the cassette by 
snipping a portion of the strip from either end.  The strip is now softly pushed into 
contact with the 2-D gel ensuring the acidic end is on the left side of the gel.  To 
push the gel in, use a piece of filter paper. 
The cassettes are then loaded into the Protean cartridges and ~3L of running 
buffer is added ensuring the space between the cassettes is full before pouring the 
remaining buffer into the tank.  Ensure the liquid buffer is not leaking as leaking 
  
 
 
will stop the flow of electricity.  Running buffer is made with glycine (115.2g), 
Tris (24g), SDS (4g), and dH2O (qs to 4L).  The machine was 250 mA.  During 
the first fifteen minutes, it is checked that there is no leaking, the dye front starts 
going down, and bubbles are rising.  Dye fronts and amp are checked periodically 
until the gel front reaches the bottom of the 2D gel and the machine is turned off.  
It is normal if the current drops over time. 
Step 6: Gel retrieval, pre-imaging, and imaging 
Gels are unloaded and put into trays containing dI H2O by carefully using the 
spacers to separate the pieces of glass containing the gel.  The gels are then eased 
into the water and orbited for five minutes at 42 rpm.  The water is then dumped 
out and a fixation solution (10% methanol and 7% acetic acid) is added and the 
gels are put back onto the orbiter for up to one hour.  At this point the fixation 
solution is put into a hazardous waste container and Sypro Ruby stain (Bio-Rad) 
is added.  The trays set on the orbit machine overnight covered in aluminum foil 
to prevent ultraviolet radiation from degrading the stain.  Finally, a 24 hour 
destaining period is recommended with two solution changes using the fixation 
solution before the sample is ready to image.  For imaging, the Molecular Imager 
Gel Doc XR+ System with Image Lab Software was used with a Sypro Ruby 
stain protocol. 
Step 7: Protein extraction 
Using a UV box, gels are imaged so that selected plugs can be extracted from the 
gel for analysis.  Plugs are chosen by comparison between two different gels.  For 
this experiment, eight protein gels were chosen.  Protein plugs are extracted from 
  
 
 
the gels using a One Touch Plus Spotpicker with a 1.5 mm diameter (The Gel 
Company) and with disposable tips with floating filter for PDM 1.5 One Touch 
Plus sp (The Gel Company).  Once the spots are extracted they were put into 
microcentrifuge tubes. 
Step 8: In-Gel Digestion and Extraction 
First the gel pieces are washed by adding 100 µL dI H
2
O and letting sit for 5 
minutes before discarding the H2O.  Next a 100 µL (50:50) mixture of 100 mM 
Ammoniumbicarbonate (Sigma) and acetonitrile were added and let sit for 10 
minutes before discarding the mixture.  After adding 50 µL of acetonitrile and 
incubating for 5 minutes at 56 °C.  The liquid was discarded and the gel pieces 
were opaque and shrunken.  Gel pieces were then allowed to dry in a sealed 
dessicator for 10 minutes. 
The next step is for reduction and alkylation of the protein samples.  This step 
serves break disulfide bonds.  First, 20 µL of 10 mM D,L 1,4 Dithiothreitol 
(Acros Organics) in 10 0mM Ammoniumbicarbonate is added to each sample and 
incubated for 45 minutes at 56 °C.  Microcentrifuge tubes are removed and 
allowed to cool to room temperature before adding 20 µL of 55 mM 
iodoacetamide (Acros Organics) in 100 mM Ammoniumbicarbonate and 
incubated in darkness for one hour.  Note: for the 2 steps in reduction and 
alkylation make 100 mM  Ammoniumbicarbonate solutions then add the D,L 1,4 
Dithiothreitol and iodoacetamide in their respective molalities (i.e. for step add 10 
mM D,L 1,4 Dithiothreitol to 20 µL of 100 mM Ammoniumbicarbonate).  The 
washing process was then repeated. 
  
 
 
Next, the proteins are enzymatically cut into peptide chains using trypsin.  A 
trypsin solution is made on ice using 10 ng/µL trypsin in 4 °C 50 mM 
Ammoniumbicarbonate with 10% acetonitrile.  Each protein is rehydrating using 
15 µL of the trypsin solution and incubated for thirty minutes on ice.  
Subsequently, 10 µL of 50 mM Ammoniumbicarbonate is added to each protein 
then put into a 30 °C water bath overnight.  The microcentrifuge tubes are 
wrapped in Parafilm (Pechiney Plastic Packaging Company) to ensure that no 
water enters. 
Lastly, peptides are collected for sequencing by stopping the enzymatic reactions 
occurring with the addition of formic acid (Acros Organics) to the final 
concentration of 1.0%.  The supernatant was removed and saved.  Afterward, the 
addition of 30 µL of 50% acetonitrile with 5% formic acid to each protein was 
allowed to sit for 45 minutes before sonicating at 100% for five minutes.  The 
supernatant was removed and saved with the previous supernatant. The previous 
step was repeated again to ensure maximum collection.  Lastly, the addition of 30 
µL of 90% acetonitrile with 5% formic acid to each protein was allowed to sit for 
5 minutes.  The supernatant was removed and added to the other supernatants of 
the respective proteins.  The supernatants were dried in a dessicator.  Samples 
were sent to Cornell’s Proteomics and Mass Spectrometry Facility. During initial 
drying process two protein plugs were lost due to the variation in air pressure. 
2.5 Statistical Analysis 
All the data was obtained and compared to multiple results and expressed as 
averages +/- standard deviations.  One-way ANOVA at a significance of p < 0.05 
  
 
 
was performed using Microsoft Excels Data Analysis package.  In addition, some 
tests were analyized using the two-tail 95% confidence t-test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
3. Results 
3. 1 DC treatment of human cells in a planktonic suspension 
In order to understand the cytotoxicity of DC treatment, three different human cell 
lines were tested in an aqueous solution for one hour with current levels of 500µA 
or 600µA (or 70 - 84 µA/cm² DC).  The three cell lines used were Lung Cancer 
5908, Lung Cancer 5803, and Breast Cancer 231.  Figure 4 shows the results of 
this test.  For cell line BC 231, cell viability was only decreased by 7.19% with 1h 
treatment at 70 µA/cm² DC. for 500µA.  For cell line LC 5803, cell viability 
decreased by 7.83% during with 1h treatment at 70 µA/cm² DC.  For cell line LC 
5908, cell viability decreased by 9.24% during with 1h treatment at 70 µA/cm² 
DC. Overall, the results showed that there is no major toxicity to human cells with 
DC treatment at the same DC levels the was found effective against P. 
aeruginosa. 
The testing with 600µA DC on mammalian cells showed levels of cytotoxicity 
too high to consider for co-culture tests.   This is due to a 64% reduction in cell 
count during one hour of treatment.
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3.2 Effect of DC on the viability of human cells infected with PA01 
To determine if we can selectively kill P. aeruginosa in co-coltures, the viability 
of human cells infected with PA01 under electric currents and in the presence of 
the antibiotic Tobramycin was tested. 
The first test was designed to determine the effectiveness of 1.5 µg/mL of 
tobramycin with DC treatment on mammalian cells infected with PA01. The cell 
lines LC 5908 and LC 5803 were tested with 1.5 µg/mL tobramycin.  The two 
tests showed less than 1 log killing of bacteria after one hour of DC treatment.  
Thus the use of 1.5 µg/mL tobramycin was not sufficient to obtain significant 
killing of PA01. This led to a test using 3.0 µg/mL to see if killing would be 
achieved with increased tobramycin concentration.  As for the mammalian cell 
longevity, neither tobramycin concentration showed significant effects on cell 
death.  To demonstrate the viability of human cells infected with PA01, tests were 
set up with cell line LC 5908 and PA01 and treated with 3 µg/mL tobramycin for 
one hour of 500 µA DC treatment.  After one hour treatment LC 5908 showed a 
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5% and 12% decrease in viability for the test with and without Tobramycin.  
More than two logs of killing was achieved for bacteria in the presence of 
tobramycin compared to 1 log killing of bacteria in the absence of tobramycin. 
The two tests showed that with the use 3.0 µg/mL there was over two-log killing 
of PA01.  In contrast, there was less than one log killing with 1.5 µg/mL 
tobramycin.  Interestingly, the tests run as a control for the 3.0 µg/mL (exclusion 
of antibiotic) showed 1 log killing, but the test run as a control for the 1.5 µg/mL 
showed no killing.  Overall, synergy was observed between 70 µA/cm2 and 3 
µg/mL in killing P. aeruginosa PAO1 in co-cultures with Lung Cancer 5908 
cells.  This condition was found to be safe to human cells. 
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3.3 Determination of appropriate sonication protocol for 2DE analysis 
To better understanding appropriate time and power levels for sonication, 
different levels of sonication were tested.  The following images show the two 
different tests that were run to gain a better understanding of how different levels 
of sonication affected the degree of proteins harvested.  The first test (Image 4) 
showed that the amount of sonication at its maximum of three minutes was still 
not enough to obtain results from the supernatant where the proteins should be 
found. The images show that as sonication time increase and intensity increased 
there were no effects on the amount of protein bands and their respective 
densities.  This meant that there was a necessity to run the test with the lysis 
buffer to help break down the cells before sonication. 
Due to this, the next test was designed to use 100% sonication at one minute time 
intervals between one and five minutes with 200 µL of lysis buffer.  The results 
showed that sonication of three, four, and five minutes led to similar results once 
lysis buffer was used, whereas, sonication of less than two minutes resulted in less 
protein densities in the 1D gels (Image 5).  As a conclusion of this experiment, 
parameters for the protocol for the variable protein expression mapping due to 
electrochemical treatment experiment were set and results were improved.  
Finally in Image 6, results for 2D PAGE show how results improve dramatically.  
The first image lacks a lot of proteins spots and those that are present are not well 
spread out.  The second image shows an abundance of protein spots well spread 
Out on the gel.   
  
 
 
 
 
Image 4: The test results show how varying time and intensity of sonication 
affect the amount of protein present in the pellet and supernatant.  From left to 
right the test shows: (1) Ladder, (2) Supernatant: 75% 2:00 min, (3) Pellet: 75% 
1:30 min, (4) Supernatant: 75% 1:30 min, (5) Supernatant: 50% 3:00 min, (6) 
Pellet: 50% 3:00 min, (7) Pellet: 50% 2:00 min, (8) Supernatant: 50% 2:00 min, 
(9) Pellet: 50% 1:30 min, (10) Supernatant: 50% 1:30 min, (11) Pellet: 75% 
2:00 min, (12) Supernatant: 75% 3:00 min, (13) Pellet: 75% 3:00 min, (14) 
Supernatant: 100% 1:30 min, (15) Pellet: 100% 1:30 min, (16) Supernatant: 
100% 2:00 min, (17) Pellet: 100% 2:00 min, (18) Supernatant: 100% 3:00 min, 
(19) Pellet: 100% 3:00 min, and (20) Ladder. 
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3.4 Differential protein expression P. aeruginosa in response to DC treatment
In order to better understand the mechanism of bacteria killing
expression of P. aeruginosa
Because the protocol used was designed for 
Image 6: The protein gel
optimizing the protocol. 
Image 5: The test results show how varying time at 100% sonication with 
lysis buffer affects the presence of proteins in the supernatant.  Tim
right to left are (1) 1 minute, (2) 3 minutes, (3) 2 minutes, (4) 4 minutes, and 
(5) 5 minutes. 
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done using the technique to ensure that proper and accurate results were achieved.  
Further, 1D gel tests were run to examine how varying degrees of intensity at 
different time intervals of sonication affected the yield and separation of proteins.  
Our results showed that sonication for five minutes at 100% power gave best 
results.  By comparing 2DE images of the control and DC treated samples of 
several proteins, up- or down- regulated by DC were identified.  Six represented 
proteins were sampled from the gels.  Four of them were processed with in-gel 
digestion with trypsin and sent to the proteomic facility at Cornell University for 
protein identification by sequencing.  Protein spot 1 and 3 were found up-
regulated and extracted from the treated bacteria.  Protein spot 1 was identified to 
be a 50s ribosomal protein L25 which assists in protein formation, stops peptidyl 
hydrolysis, and supports peptide bond formation.  Protein spot 3 was found to be a 
stress protein, which is expressed in consistent anaerobic conditions due to energy 
starvation.  Protein spots 4 and 5 were found down-regulated and extracted from 
the control bacteria.  Protein spot 4 was found to be outer membrane porin F, 
which allows for passive diffusion of glucose, nutrients, ions, and water.  Protein 
spot 5 was found to be DsbA, which is a soluble thiol:disulfide oxidoreductase  
periplasmic protein (responsible for froming disulfide bonds in proteins) and 
necessary for type III secretion system.  Type III secretion system is made of a 
protein appendage used to detect eukaryotic cells and influence protein expression 
for bacterial infection (proteins are directly secreted into bacteria).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Image 7: The control and treatment gels that show the proteins that were chosen and 
extracted for protein identification. 
  
 
 
4. Discussion 
The application of the bioelectric effect has shown good potential for helping 
improve the efficacy of antibiotics for the treatment of chronic infections.  This is 
especially important for elderly and young persons with weak or under developed 
immune systems as well with persons with diseases that decrease the functionality 
of their immune system such as HIV and AIDS or cystic fibrosis. The 
advancement in understanding the effects of DC treatment on human cells as well 
as bacterial cells will help advance this technology against bacteria. 
Tests with human cells have shown there to be no majord cytotoxic effects from 
the application of DC current at 500 µA (70 µA/cm2) , but the increase of DC 
current to 600 µA (84 µA/cm2) was shown to have noticeable effects on human 
cells.  Thus further experiments with bacteria and tobramycin were centered at 
500 µA or 70 µA/cm2.  
Follwing the cytotoxicity study, this work progressed to a co-culture model of 
human cells and bacterial cells treated together with DC and tobramycin.  This 
test was important for understanding the effect of DC treatment and antibiotics on 
a suspension of PA01 and human cells.   
As for the relative cytotoxicity levels of the bioelectric effect, another innovative 
idea for the treatment of antibiotic resistant bacteria is through the use of 
nanoparticles.  The use of the bioelectric effect has some distinct advantages over 
nanoparticles.  First, the treatment itself does not involve a physical entity that 
requires degradation by the body.  The use of nanoparticles requires there to be 
research into the biocompatibility and mechanical properties of the material.  
  
 
 
There are potential issues with how and where nanoparticles would degrade and 
what the degraded nanoparticles could cause.  One proposed issue is the 
accumulation of nanoparticles in intracellular areas leading to organelle disruption 
or gene alterations [12].  A study conducted by Pulskamp et. al. found a 60-80% 
reduction in cell longevity as a result of the use of carbon nanotubes [13]. 
The use of the bioelectric effect to control biofilms has been previously studied, 
but little has ever been researched and understood about the mechanisms of this 
phenomenon.  Previous researchers have found efficacy between the uses of 
antibiotics with varying electrical currents [17], but the effects on mammalian 
cells were not tested.  A study by Costerton et. al. suggested that killing of 
bacteria is not reliant the generation of ions or antibacterial particles due to the 
local electrochemical generation [10].  It has been shown that the stainless steel 
oxide film helps maintain the electrodes stability.  When breakdown of the oxide 
film occurs, passivation occurs, disrupting the oxide film, and leading to 
corrosion.  This is especially important for applications concerning the bioelectric 
effect because oxide films are easily disrupted when the electrical current 
becomes too high or too low and as the pH of the environment decreases.  This is 
not a major issue as the electrodes will only be implanted temporarily, but it is 
important that any alloys present on the electrodes be safe in the body as a result 
of corrosion of the electrodes [11].  Furthermore, there is potential that the 
oxidation and reduction reactions that are occurring could contribute to the 
efficacy found between antibiotics and DC treatment.  To better understand the 
potential that exists to expand upon this, tests will be run to see how higher 
  
 
 
antibiotic concentrations continue to reduce the viability of PA01 and if there is a 
plateau reached where increased concentrations of the antibiotic have no further 
effect.   
Results from the co-culture study show the drastic increase in microbial killing as 
the concentration of antibiotics is increased from 1.5 µg/mL to 3.0 µg/mL.  This 
suggests that there may be a threshold concentration of tobramycin for killing 
PAO1. 
The proteomic results provide new insight into how the bacteria cells are reacting 
to DC treatment at the protein level.  The 1st spot contained was identified to be a 
50s ribosomal protein L25 which assists in protein formation, stops peptidyl 
hydrolysis, and supports peptide bond formation.  For spot 3, stress proteins were 
found.  Cells respond to stressful environments by the synthesis of stress proteins 
such as the one extracted at spot 1.  Stress proteins are synthesized to help with 
the stressful environments, but given that the bacteria would have no genetic 
information about electrical treatment, the response is probably a standard 
response not specific to ec treatment. 
Protein spots 4 and 5 were found down-regulated and extracted from the control 
bacteria.  Protein spot 4 was found to be outer membrane porin F, which allows 
for passive diffusion of glucose, nutrients, ions, and water.  Protein spot 5 was 
found to be DsbA, which is a soluble thiol:disulfide oxidoreductase  periplasmic 
protein (responsible for froming disulfide bonds in proteins) and necessary for 
type III secretion system.  Type III secretion system is made of a protein 
appendage used to detect eukaryotic cells and influence protein expression for 
  
 
 
bacterial infection (proteins are directly secreted into bacteria).  These spots show 
that the DC treatment is somehow preventing bacteria from infecting human cells 
by preventing the formation of the Type III secretion systems.  The formation 
prevention is not from tobramycin as it was not involved in this test.  Also it 
appears that since out membrane porin F is down regulated, the bacterium I 
working to maintain intracellular homeostasis by preventing the influx of ions, 
nutrients, water, and glucose. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Conclusion 
In this study, we demonstrated that DC treatment at 70 μA/cm2 is safe to human 
cells.  Furthermore, the co-culture study showed that DC treatment at 70 μA/cm2 
has the ability to selectively kill bacterial cells without causing harm to human 
cells.  The ffective concentration of tobramycin for co-treatment with DC was 
found to be 3.0 µg/mL.  To understand the effects of DC on P. aeruginosa at 
molecular level, the protocol to harves cellular proteins was optimized to use 
sonication with lysis buffer. Upon extraction of proteins and comparison between 
control and DC treatment, ADD NAMES proteins were found to be up- and 
down- regulated by DC treatment, respectively.  Overall, this study provided 
important understanding to missing  information for bacterial control by DC and 
for developing more effective therapies to control chronic infection. 
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Capstone Summary 
 The project set up is entitled “Controlling bacterial persister cells with low 
level electric currents.”  The project is designed to understand three different 
fields related to the study of killing antibiotic resistant bacteria using electrical 
currents.  The three prongs of the study focus on the potential cytotoxicity of 
electrical currents, viability of human cells treated with an infectious bacteria 
(Pseudomonas aeruginosa strand PA01), and variable protein expression of PA01 
due to the prolonged application of electrical currents.  So what does each prong 
really mean? 
 The first study on the cytotoxicity of electrical currents means the study is 
designed to measure if using electrical currents on human cells would harm 
human cells.  If something is cytotoxic it is effectively harmful to the cells. It is 
important to note these human cells come from companies and are professionally 
and ethically obtained. This is important because if the application of electrical 
currents, as a way to treat infectious diseases, which are antibiotic resistant, is 
proven effective, it could eventually lead to use in humans as a last resource fight 
against bacteria.  This study aims to find out whether or not the application of 
electrical currents is harmful to individual human cells and the overall human 
body longevity.  To put it another way, will the application of electrical currents 
end up hurting the body more than helping it? 
 To conduct this portion of the study, different types of cells extracted from 
the human body are grown in a solution that helps promote cell longevity.  Cells 
are grown for a week in a controlled environment before tests are run.  The cells 
  
 
 
are grown for a week such that approximately the same amounts of cells are being 
tested for each testing period.  For the tests to be done, cells are put into a cuvette, 
which is an upright rectangular container that holds the solution that contains the 
suspended human cells.  Electrodes are pieces of electrically conductive material 
that allow for the flow of electricity from one to another through a nonmetallic 
material.  By placing two electrodes in a cuvette, on opposite ends, it allows for 
the flow of currents from one electrode to the other through the aqueous medium 
(human cells suspended in a liquid solution) thus creating an electrical circuit.  
This experiment effectively puts human cells in the middle of the current flowing 
between these two electrodes.  An Ag/AgCl (silver/silver chloride) electrode is 
placed between the two electrodes to act as a reference to ensure that the amount 
of current flowing between the two electrodes is consistent.  The reference acts as 
a feedback mechanism by ensuring that the amount of current flowing from one 
electrode to the other stays constant.  In order to measure whether or not the cells 
are being harmed, samples are taken from the cuvette before ec treatment starts 
and then after twenty, forty, and sixty minutes have elapsed.  Samples are taken 
and dyed blue using Trypan blue which serves to dye the cell membrane blue such 
that cells are easy to count.  To count cells a microscope is used with a specialized 
slide that has a grid network on it.  The grid network is set up such that there are 
four sections of the grid that have a 4x4 grid of squares.  By counting the amount 
of cells in each of the four sections, an average can be taken and the amount of 
cells in the cuvette can be inferred.  The reason there are four sections is to ensure 
that a good and accurate representation is found.  By taking the amount of cells 
  
 
 
over the four time intervals (time = 0,20,40,60 minutes), the potential for 
cytotoxicity from ec treatment is determined.  Results have shown that currents 
less than 600 µA have minimal to no cytotoxic effects on the longevity of cells. 
 The next study is set up to understand how cytotoxicity might be altered 
due to the infection and presence of bacteria, Pseudomonas aeruginosa.  This 
study also aims to see how Pseudomonas aeruginosa react to the ec treatment in 
the presence of human cells and with the presence of an antibiotic, tobramycin.  
This study is more complicated in that there are more factors involved.  The 
factors being tested include: will the longevity of human cells be affected with the 
presence of bacteria, ec treatment, and antibiotics? Will killing of bacteria occur 
with the presence of human cells, ec treatment, and antibiotics?  Will killing be 
more effective because of variable concentrations of antibiotics? 
 To answer these questions, a similar technique is used as for the first study 
except a specified amount of bacteria and antibiotic is added.  The process of 
culturing bacteria is done the night before the experiment due to the incredible 
rate of bacterial reproduction.  Bacteria are grown in a liquids solution or medium 
called lysogeny broth (LB), which is high in nutrients.  To prepare bacteria for 
testing, a set amount of sample is washed with a solution known as a buffer that 
rids the LB medium.  This is done so that bacteria do not rapidly grow during 
testing.  To determine how much bacteria there is in the solution a measurement 
known as optical density is taken.  Optical density is a measure of how much light 
is able to pass through a sample at a set wavelength (600nm is used).  The amount 
of light that is absorbed by the sample correlates to the population of bacteria.  
  
 
 
For example, if the goal OD is 0.6 but an OD of 0.9 is measured, you would add 
2/3mL sample and 1/3mL buffer instead of 1mL of sample to make your sample 
the desired OD.  The addition of tobramycin is done at concentrations relative to 
studies that have shown an effective range for the antibiotic. 
 Once the experiment is setup, ec treatment is run.  At times of zero, 
twenty, forty, and sixty minutes, samples of cells and bacteria are taken and 
quantified.   The process of quantifying the bacteria is more difficult as it requires 
the dilution of the sample to a quantity that can be counted then overnight 
culturing so bacteria colonies can grow and be visible for counting.  This process 
is called plating and tells how the amount of bacteria changes as time passes for 
the experiment.  With the conclusion of this experiment, information was 
determined about the most important concentrations of trobramycin to effectively 
kill bacteria alongside ec treatment.  This has led to a lot of research being 
conducted with my mentor and myself as to why and how ec treatment increases 
the efficacy of antibiotics. 
 The last part of the study focused on understanding why bacteria are dying 
due to ec treatment by profiling protein expression.  In order to do this, a 
technique called 2D- SDS Page was used because it creates a two-dimensional 
map of the membrane proteins.  The proteins are shown on a gel material and are 
separated by the proteins’ relative charges by pH and molecular weight.  The 
proteins are displayed as black dots of varying size and darkness and can be 
extracted and sequenced to determine what specifics proteins are.  The process to 
create the protein maps takes six days and starts by creating an overnight culture 
  
 
 
and running ec treatment.  After ec treatment the cells are broken apart by a lysis 
buffer then DNA, RNA, and cell membrane fragments are broken up by a 
machine called a sonicator.  The sonicator works by applying sound energy to 
samples disrupting genetic material so it does not remain in the mixture and alter 
results.  After this, the proteins are put onto a one dimension gel strip and 
separated by pH gradient using a 24hr period of applied voltage.  Protein 
interactions are disrupted so that proteins do not attach to each other preventing 
clear results.  The last step involves the creation of gels then putting the one 
dimension gel strip on top and allowing it to run to create a two dimensional map 
of the process which shows the expression of proteins.  For this study, an 
experimental (ec treated bacteria) and a control test (not ec treated bacteria) 
showed how the protein expression of the bacteria changed.  By extracting 
proteins that changed in concentrations between the two tests, information about 
how different membrane proteins are in higher and lower concentrations will 
provide insight into how the bacteria are reacting to ec treatment.  
 The importance of this study is to examine new and innovative ways to 
kill antibiotic resistance bacteria that are becoming increasingly prominent.  This 
problem has seen rise in many hospital settings where there is a constant need to 
eradicate the presence of any potentially harmful bacteria.  The specific strand of 
bacteria tested, Pseudomonas aeruginosa, has been found to be resistant to 
multiple strands of antibiotics already.  P. aeruginosa is an opportunistic 
bacterium that leads to skin infections, issues with cystic fibrosis, and elderly 
patients with weakened immune systems.  P. aeruginosa can also lead to the 
  
 
 
formation of biofilms in nature and in hospital settings on implants.  Biofilms are 
communities of bacteria that attach to a surface in grow within an extracellular 
polymeric surface (EPS) that protects the bacteria from antibiotics and harmful 
environments until the biofilm bursts and releases the bacteria.  Biofilms are 
especially a problem as they allow for bacteria to trade genes that allow for 
widespread resistance to antibiotics.  Another potential source of antibiotic 
resistant bacteria is persister cells.  Persister cells are dormant cells that are 
practically metabolically inactive when a patient is taking their antibiotics, but 
become active again after the antibiotic regime is over and are able to repopulate 
and cause the symptoms to arise again (this is why it is very important to take 
antibiotics to completion!).  When bacteria are able to repopulate and cause an 
infection to come back there is a better chance for the bacteria to learn antibiotic 
resistance and cause potentially life threatening issues to the patients. 
Many approaches are being examined to find ways to overcome issues 
involved with antibiotic resistance, but the focus of this study is to learn more 
about the use of the bioelectric effect.  The bioelectric effect aims to treat bacteria 
with antibiotics and electrical currents in order to increase the efficiency of the 
antibiotics.  The project has helped prove that no harmful effects have been shown 
by using the bioelectric effect on varying strands of human cells.  In addition, the 
study has delved into the level of electrical current applied and the amount of 
antibiotic used to maximize killing of bacteria while ensuring the longevity of 
human cells.  The future of the bioelectric effect is looking into how the use of 
electrical currents helps improve efficacy of antibiotics by examining how the 
  
 
 
antibiotics are transported into the cell.  In addition, a sinus infection will be 
induced on an animal model to test how an actual animal reacts to DC treatment. 
 
